These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12894483)

  • 41. Time-kill studies on susceptibility of nine penicillin-susceptible and -resistant pneumococci to cefditoren compared with nine other beta-lactams.
    Spangler SK; Jacobs MR; Appelbaum PC
    J Antimicrob Chemother; 1997 Feb; 39(2):141-8. PubMed ID: 9069533
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from adults in China during 2009 and 2010].
    Wang H; Liu YL; Chen MJ; Xu YC; Sun HL; Yang QW; Hu YJ; Cao B; Chu YZ; Liu Y; Zhang R; Yu YS; Sun ZY; Zhuo C; Ni YX; Hu BJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2012 Feb; 35(2):113-9. PubMed ID: 22455967
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Antibiotic resistance and serotype distribution of Streptococcus pneumoniae strains isolated from patients at Hacettepe University Medical Faculty].
    Yenişehirli G; Sener B
    Mikrobiyol Bul; 2003 Jan; 37(1):1-11. PubMed ID: 12838672
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Susceptibility patterns of Streptococcus pneumoniae isolates in North America (2002-2003): contemporary in vitro activities of amoxicillin/clavulanate and 15 other antimicrobial agents.
    Pottumarthy S; Fritsche TR; Sader HS; Stilwell MG; Jones RN
    Int J Antimicrob Agents; 2005 Apr; 25(4):282-9. PubMed ID: 15784306
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro activity of ceftaroline against Streptococcus pneumoniae isolates exhibiting resistance to penicillin, amoxicillin, and cefotaxime.
    Fenoll A; Aguilar L; Robledo O; Giménez MJ; Granizo JJ; Biek D; Tarragó D
    Antimicrob Agents Chemother; 2008 Nov; 52(11):4209-10. PubMed ID: 18725443
    [No Abstract]   [Full Text] [Related]  

  • 46. Antimicrobial Activity of Zabofloxacin against Clinically Isolated Streptococcus pneumoniae.
    Park HS; Oh SH; Kim HS; Choi DR; Kwak JH
    Molecules; 2016 Nov; 21(11):. PubMed ID: 27869677
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antibacterial activity of TOC-50, a new parenteral cephalosporin against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
    Nomura S; Hanaki H; Furukawa T; Unemi N
    Chemotherapy; 1997; 43(1):1-5. PubMed ID: 8996734
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Crystal structure of cefditoren complexed with Streptococcus pneumoniae penicillin-binding protein 2X: structural basis for its high antimicrobial activity.
    Yamada M; Watanabe T; Miyara T; Baba N; Saito J; Takeuchi Y; Ohsawa F
    Antimicrob Agents Chemother; 2007 Nov; 51(11):3902-7. PubMed ID: 17724158
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cefditoren in upper and lower community-acquired respiratory tract infections.
    Soriano F; Giménez MJ; Aguilar L
    Drug Des Devel Ther; 2011 Feb; 5():85-94. PubMed ID: 21340042
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Emergence of fluoroquinolone-resistant Streptococcus pneumoniae in Lebanon: a report of three cases.
    Naba MR; Araj GF; Baban TA; Tabbarah ZA; Awar GN; Kanj SS
    J Infect Public Health; 2010; 3(3):113-7. PubMed ID: 20869671
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combination of Cefditoren and
    Llamosí M; Sempere J; Coronel P; Gimeno M; Yuste J; Domenech M
    Microbiol Spectr; 2022 Dec; 10(6):e0341522. PubMed ID: 36445126
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In Vitro Activity of Lefamulin Tested against Streptococcus pneumoniae with Defined Serotypes, Including Multidrug-Resistant Isolates Causing Lower Respiratory Tract Infections in the United States.
    Mendes RE; Farrell DJ; Flamm RK; Talbot GH; Ivezic-Schoenfeld Z; Paukner S; Sader HS
    Antimicrob Agents Chemother; 2016 Jul; 60(7):4407-11. PubMed ID: 27161634
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Twelve-year survey (2001-2012) of the antimicrobial susceptibility of Streptococcus pneumoniae isolates from otorhinolaryngology clinics in Miyagi Prefecture, Japan.
    Ozawa D; Yano H; Hidaka H; Kakuta R; Komatsu M; Endo S; Kanamori H; Kaku M; Katori Y
    J Infect Chemother; 2014 Nov; 20(11):702-8. PubMed ID: 25131291
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro activity of new cephalosporins vs Streptococcus pneumoniae from the Canadian Bacterial Surveillance Network: 2008-2011.
    Green K; McGeer A; Rudnick W; Pong-Porter S; Patel SN; Low DE;
    Curr Microbiol; 2014 Nov; 69(5):763-7. PubMed ID: 25023636
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Treatment of penicillin-resistant pneumococcal infections in adults].
    Falcó Ferrer V; Pahissa Berga A
    Rev Clin Esp; 2003 May; 203(5):244-7. PubMed ID: 12765573
    [No Abstract]   [Full Text] [Related]  

  • 56. In vivo Pharmacokinetics/Pharmacodynamics Profiles for Appropriate Doses of Cefditoren pivoxil against S. pneumoniae in Murine Lung-Infection Model.
    Igarashi Y; Kojima N; Takemura W; Liu X; Morita T; Mizukami Y; Enoki Y; Taguchi K; Yokoyama Y; Nakamura T; Matsumoto K
    Pharm Res; 2023 Jul; 40(7):1789-1797. PubMed ID: 37253866
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [A clinical study on cefditoren pivoxil granules in the pediatric field].
    Mori A; Meguro H; Terashima I; Fujii R
    Jpn J Antibiot; 1993 Jul; 46(7):577-88. PubMed ID: 8371493
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Activities of RPR 106972 (a new oral streptogramin), cefditoren (a new oral cephalosporin), two new oxazolidinones (U-100592 and U-100766), and other oral and parenteral agents against 203 penicillin-susceptible and -resistant pneumococci.
    Spangler SK; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1996 Feb; 40(2):481-4. PubMed ID: 8834904
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [A new antibiotic against respiratory tract infections. More power against pneumococci].
    MMW Fortschr Med; 2001 Nov; 143(44):59. PubMed ID: 11732406
    [No Abstract]   [Full Text] [Related]  

  • 60. In vitro and in vivo antibacterial activity and pharmacokinetics of SC-002 and its derivative, SC-004: new oral cephalosporins.
    Nagate T; Akashi T; Numata K; Sugita K; Kaneda Y; Matsuyama M; Saito H; Nozawa M; Onodera A; Hanada K; Kobori T; Fujita M; Yamamoto R; Hiyama T; Kondo K
    Chemotherapy; 2001; 47(3):157-69. PubMed ID: 11306784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.